In spite of concern about cancer, a cancer monitoring system covering
all countries of the European Union has not yet been implemented.
A large-scale Health Monitoring Program (HMP) to establish health
indicators for the European Union and for all diseases was yet implemented,
giving a reasonable way to reach this important European goal. Cancer
surveillance holds a privileged position, compared to other diseases,
in terms of sources for collecting data, matured experience and
availability of data. Population-based cancer registries covering
entire countries and millions of other Europeans, whose initial
purpose was to collect data on cancer occurrence, are now progressively
providing much more detailed information on cancer, including diagnostic
criteria and therapeutic procedures at individual level. More information
on social-economic health variables, both at aggregated and individual
levels, is now becoming available in European networks and institutions.
For these reasons the project on cancer on these topics may propose
useful methods and standards for developing the European Health
The present project, EUROpean Cancer Health Indicator Project- EUROCHIP-,
was conceived as a contribute to the HMP and to produce a comprehensive
list of health indicators pertaining to the control and treatment
of cancer, indispensable for the development of the set of European
health surveillance indicators.
EUROCHIP aimed to develop a comprehensive list of health indicators
on cancer according to numerous European cancer experts. The list
includes variables on risk factors’ prevalence, pre-clinic
activity, cancer occurrence, clinical follow-up, cancer recurrences,
patient survival, diagnostic and therapeutic procedures, effectiveness
of cancer care, outcome and care prevalence. The list includes both
variables that had already been proposed by other HMP projects and
new variables that are specific for cancer and had not been suggested
from other HMP projects.
The present project will assess the internal consistency of all
these data according to criteria of easy collection, reliability,
comparability, and country representatives. Moreover, the gained
experience in the development of cancer health indicators will be
centralized. The final aim will be to make available a comprehensive
list of indicators that would describe cancer in terms of burden,
prevention activity, standards of care, and cure rates.
In synthesis EUROCHIP-1’s main work and results are:
- Contact and co-ordinate people involved in different fields
from different countries to develop the complex organization
of the project. 130 persons from all the European countries
have been directly involved in the project.
- Organize several meetings in Europe: 4 Steering Committee
meetings, 3 Panel of Experts meetings, 3 Methodological Group
meetings, 8 National Groups of Specialists meetings and 5 Domain
Groups of Specialists meetings.
- Create forms to describe the indicators and their methodological
aspects upon which all would agree
- Develop a list of indicators and organize discussions on
- Fill the forms for each indicator and provide an operational
definition and proposals regarding methodological problems.
- Present the list to the audiences of national and international
cancer congresses in order to improve consensus on the indicators.
- Publish articles on scientific journals- share methods and
||EUROCHIP-1 Final Report